Oxford Vaccine

South Africa's COVID-19 vaccine trials saved the world from another long year of surprises

the trial in South Africa underscored the need to stamp out the virus before it mutates further.

AstraZeneca vaccine has higher efficacy against COVID-19 with a three-month gap between doses, says Oxford study

The study, published in The Lancet, suggests that the interval between doses can be safely extended to three months than a six-week gap as the first dose can offer up to 76 percent protection during that period

Will combining Oxford's vaccine with Russia's Sputnik V make it more effective?

It’s not yet known why reduced-dose of the Oxford vaccine showed better efficacy in trials, but it could be down to the viral vector.

AstraZeneca COVID-19 vaccine doesn't work well against South Africa virus variant: Study

The developments, which came nearly a week after 1 million doses of the vaccine arrived in South Africa, were a huge setback for the country.

Oxford finds AstraZeneca COVID-19 shot 76% effective in second, third month after single dose

Oxford claims the vaccine also reduces transmission, with as much as a 67 percent drop in the risk of a positive COVID-19 swab test.

Health experts voice doubts, concerns about hurried approval process for Bharat Biotech’s Covaxin

Balram Bhargava, head of ICMR said the “restricted use” of a vaccine on the basis of data from early clinical trials is legally possible in a pandemic.

AIPSN urges govt to reconsider emergency approval for Covaxin till Phase 3 data is published

Either pausing or cancelling approvals is not unheard of, and the CDSCO does have the authority to do so.

Morocco gives approval for emergency use of Oxford-AstraZeneca's COVID-19 vaccine

The approval comes as preparations for Morocco’s vaccine rollout have reached “advanced stages,” the Health Ministry said.

Mexico approves Oxford-AstraZeneca COVID-19 vaccine for emergency use

The country, which has its hopes pinned on the inexpensive, one-shot Chinese CanSino vaccine, had only authorised the use of Pfizer vaccine so far

As more COVID-19 vaccines get approval, experts debate if it's time for trial volunteers to get the real thing

In an ideal world, vaccine trial participants could hold off to discover whether they received the dummy shot or the vaccine. But experts agree the current circumstances are extraordinary